Tumor-associated macrophages (TAMs) promote the immune suppressive microenvironment inside tumors and are, therefore, considered as a promising target for the next generation of cancer immunotherapies. To repolarize their phenotype into a tumoricidal state, the Toll-like receptor 7/8 agonist imidazoquinoline IMDQ is site-specifically and quantitatively coupled to single chain antibody fragments, so-called nanobodies, targeting the macrophage mannose receptor (MMR) on TAMs. Intravenous injection of these conjugates result in a tumor-and cell-specific delivery of IMDQ into MMR high TAMs, causing a significant decline in tumor growth. This is accompanied by a repolarization of TAMs towards a pro-inflammatory phenotype and an increase in anti-tumor T cell responses. Therefore, the therapeutic benefit of such nanobody-drug conjugates may pave the road towards effective macrophage re-educating cancer immunotherapies.

Multiarm star copolymers, consisting of hyperbranched poly­(ethylene oxide) (hbPEO) or poly­(butylene oxide) (hbPBO) polyether copolymers with glycerol branching points as a core, and linear aliphatic polycarbonate arms generated from carbon dioxide (CO2) and epoxide monomers, were synthesized via a “core-first” approach in two steps. First, hyperbranched polyether polyols were prepared by anionic copolymerization of ethylene oxide or 1,2-butylene oxide with 8–35% glycidol with molecular weights between 800 and 389,000 g·mol–1. Second, multiple arms were grown via immortal copolymerization of CO2 with propylene oxide or 1,2-butylene oxide using the polyether polyols as macroinitiators and (R,R)-(salcy)-CoCl as a catalyst in a solvent-free procedure. Molecular weights up to 812,000 g·mol–1 were obtained for the resulting multiarm polycarbonates, determined by online viscometry with universal calibration and 1H NMR. Comparing the synthesis of different multiarm star polycarbonates, a combination of a highly reactive macroinitiator with a less reactive epoxide monomer was found to be most suitable to obtain well-defined structures containing up to 88 mol% polycarbonate. The multiarm star copolymers were investigated with respect to their thermal properties, intrinsic viscosity, and potential application as polyols for polyurethane synthesis. Glass transition temperatures in the range from −41 to +25 °C were observed. The intrinsic viscosity could be adjusted between 5.4 and 17.3 cm3·g–1 by varying the ratio of polyether units and polycarbonate units.

The development of controlled biodegradable materials is of fundamental importance in immunodrug delivery to spatiotemporally controlled immune stimulation but avoid systemic inflammatory side effects. Based on this, polycarbonate nanogels are developed as degradable micellar carriers for transient immunoactivation of lymph nodes. An imidazoquinoline-type TLR7/8 agonist is covalently conjugated via reactive ester chemistry to these nanocarriers. The nanogels not only provide access to complete disintegration by the hydrolysable polymer backbone, but also demonstrate a gradual disintegration within several days at physiological conditions (PBS, pH 6.4-7.4, 37 °C). These intrinsic properties limit the lifetime of the carriers but their payload can still be successfully leveraged for immunological studies in vitro on primary immune cells as well as in vitro. For the latter, a spatiotemporal control of immune cell activation in the draining lymph node is found after subcutaneous injection. Overall, these features render polycarbonate nanogels a promising delivery system for transient activation of the immune system in lymph nodes and may consequently become very attractive for further development toward vaccination or cancer immunotherapy. Due to the intrinsic biodegradability combined with the high chemical control during the manufacturing process, these polycarbonate-based nanogels may also be of great importance for clinical translation.

To target nanomedicines to specific cells, especially of the immune system, nanobodies can be considered as an attractive tool, as they lack the Fc part as compared to traditional antibodies and, thus, prevent unfavorable Fc-receptor mediated mistargeting. For that purpose, we have site-specifically conjugated CD206/MMR-targeting nanobodies to three types of dye-labeled nanogel derivatives: non-degradable nanogels, acid-degradable nanogels (with ketal crosslinks), and single polymer chains (also obtained after nanogel degradation). All of them can be obtained from the same reactive ester precursor block copolymer. After incubation with naïve or MMR-expressing Chinese hamster ovary (CHO) cells, a nanobody mediated targeting and uptake could be confirmed for the nanobody-modified nanocarriers. Thereby, the intact nanogels that display nanobodies on their surface in a multivalent way showed a much stronger binding and uptake compared to the soluble polymers. Based on their acidic pH-responsive degradation potential, ketal crosslinked nanogels are capable of mediating a transient targeting that gets diminished upon unfolding into single polymer chains after endosomal acidification. Such control over particle integrity and targeting performance can be considered as highly attractive for safe and controllable immunodrug delivery purposes.

Reversible modifications of reversible addition–fragmentation chain transfer (RAFT)‐polymerization derived end groups are usually limited to reductive degradable disulfide conjugates. However, self‐immolative linkers can promote ligation and traceless release of primary and secondary amines as well as alcohols via carbonates or carbamates in β‐position to disulfides. In this study, these two strategies are combined and the concept of self‐immolative RAFT‐polymer end group modifications is introduced: As model compounds, benzylamine, dibenzylamine, and benzyl alcohol are first attached as carbamates or carbonates to a symmetrical disulfide, and in a straightforward one‐pot reaction these groups are reversibly attached to aminolyzed trithiocarbonate end groups of RAFT‐polymerized poly(N,N‐dimethylacrylamide). Quantitative end group modification is confirmed by 1H NMR spectroscopy, size exclusion chromatography, and mass spectrometry, while reversible release of attached compounds under physiological reductive conditions is successfully monitored by diffusion ordered NMR spectroscopy and thin layer chromatography. Additionally, this concept is further expanded to protein‐reactive, self‐immolative carbonate species that enable reversible bioconjugation of lysozyme and α‐macrophage mannose receptor (MMR) nanobodies as model proteins. Altogether, self‐immolative RAFT end group modifications can form the new basis for reversible introduction of various functionalities to polymer chain ends including protein bioconjugates and, thus, opening novel opportunities for stimuli‐responsive polymer hybrids.